Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial spa: a prospective multicentre cross-sectional study
F Proft, J Schally, HC Brandt… - Therapeutic …, 2022 - journals.sagepub.com
Objectives: The objective of the study was to validate the Ankylosing Spondylitis Disease
Activity Score (ASDAS) based on a quick quantitative C-reactive protein (qCRP) assay …
Activity Score (ASDAS) based on a quick quantitative C-reactive protein (qCRP) assay …
[HTML][HTML] Interim 2-year analysis from SERENA: a real-world study in patients with psoriatic arthritis or ankylosing spondylitis treated with secukinumab
U Kiltz, PP Sfikakis, K Gaffney, A Bounas… - Rheumatology and …, 2022 - Springer
Introduction Sustained improvement of high degree in clinical outcomes have been
demonstrated in phase 3 trials with secukinumab in both psoriatic arthritis (PsA) and …
demonstrated in phase 3 trials with secukinumab in both psoriatic arthritis (PsA) and …
THU0399 How do TNF-alpha-inhibitors in medical history affect patient reported outcomes and retention in ankylosing spondylitis patients treated with secukinumab in …
U Kiltz, J Brandt-Juergens, P Kaestner, E Riechers… - 2020 - ard.bmj.com
Background: Secukinumab (SEC), a fully human monoclonal antibody that selectively
inhibits interleukin 17A, is approved for treatment of patients with ankylosing spondylitis …
inhibits interleukin 17A, is approved for treatment of patients with ankylosing spondylitis …
Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a …
F Proft, J Schally, HC Brandt, J Brandt-Juergens… - RMD open, 2022 - rmdopen.bmj.com
Objectives This study aimed to evaluate the Disease Activity index for PSoriatic Arthritis
(DAPSA) based on a quick quantitative C reactive protein (qCRP) assay (Q-DAPSA) in a …
(DAPSA) based on a quick quantitative C reactive protein (qCRP) assay (Q-DAPSA) in a …
[HTML][HTML] An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis
L Watson, C Coyle, C Whately-Smith, M Brooke… - …, 2023 - academic.oup.com
Objectives Shared decision-making (SDM) is advocated to improve patient outcomes in PsA.
We analysed current prescribing practices and the extent of SDM in PsA across Europe …
We analysed current prescribing practices and the extent of SDM in PsA across Europe …
AB0751 how does body mass index affect secukinumab treatment outcomes and safety in patients with ankylosing spondylitis?–real world data from the German …
U Kiltz, J Brandt-Juergens, P Kaestner, E Riechers… - 2022 - ard.bmj.com
Background Obesity is a risk factor for worse overall health in people with ankylosing
spondylitis (AS) 1. The German non-interventional study AQUILA provides real-world data in …
spondylitis (AS) 1. The German non-interventional study AQUILA provides real-world data in …
POS1013 how does body mass index affect secukinumab treatment outcomes and safety in patients with psoriatic arthritis?–real world data from the German AQUILA …
U Kiltz, J Brandt-Juergens, P Kaestner, E Riechers… - 2022 - ard.bmj.com
Background There is a higher prevalence of obesity in patients (pts) with psoriatic disease 1.
The German non-interventional study AQUILA provides real-world data on the influence of …
The German non-interventional study AQUILA provides real-world data on the influence of …
P178 Current prescribing practices in psoriatic arthritis-comparison between the UK and Europe
L Watson, C Coyle, M Brooke, U Kiltz, E Lubrano… - …, 2023 - academic.oup.com
Abstract Background/Aims Psoriatic arthritis (PsA) is a multi-system disease with a range of
management options. Treatment may vary by geographic location. We compared disease …
management options. Treatment may vary by geographic location. We compared disease …
P179 Shared decision-making in psoriatic arthritis consultations
LL Watson, C Coyle, M Brooke, U Kiltz… - …, 2023 - academic.oup.com
Background/Aims A personalised approach is required to optimise management of psoriatic
arthritis (PsA). Shared decision-making between physician and patient is key, resulting in …
arthritis (PsA). Shared decision-making between physician and patient is key, resulting in …
How do patient reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of …
C Coyle, L Watson, C Whately-Smith… - …, 2024 - hal.sorbonne-universite.fr
Objectives The ASSIST study investigated prescribing in routine psoriatic arthritis (PsA) care
and whether the patient reported outcome: PsA Impact of Disease questionnaire (PsAID-12) …
and whether the patient reported outcome: PsA Impact of Disease questionnaire (PsAID-12) …